Department of Ophthalmology, Academy of Silesia, Katowice, Poland.
Department of Ophthalmology, Optegra Clinic in Katowice, Katowice, Poland.
Med Sci Monit. 2023 Mar 17;29:e939691. doi: 10.12659/MSM.939691.
BACKGROUND This prospective study, from a single center in Poland, aimed to evaluate the correction of residual ametropia, or refractive errors, after corneal grafting using femtosecond laser-assisted in situ keratomileusis (Femto-LASIK) in 60 patients (96 eyes) who had previously undergone deep anterior lamellar keratoplasty (DALK) compared with that achieved in 60 patients (108 eyes) who underwent vision correction using Femto-LASIK alone. MATERIAL AND METHODS The study group included 60 patients (96 eyes) whose residual ametropia was corrected using the Femto-LASIK procedure after having previously undergone DALK. The comparison group consisted of 60 patients (108 eyes) who underwent vision correction with the Femto-LASIK procedure without previously having undergone DALK. Uncorrected vision acuity, best-corrected vision acuity, and intraocular pressure were measured for both groups before the procedures and at 3, 6, 12, and 24 months after the procedures. Corneal endothelial cell density was evaluated by non-contact specular microscopy before the procedures and at 6, 12, and 24 months after the procedures. RESULTS In the study group, within the 24-month observation period, no transplant rejection, transplant decompensation, or corneal ectasia were noted. Statistical analysis did not show any significant differences between the best-corrected vision acuity values in the study group in the preoperative and postoperative periods (P>0.05). In contrast, uncorrected vision acuity values were significantly higher in patients during the postoperative period than the preoperative period (P>0.05). CONCLUSIONS The effects of vision correction with the Femto-LASIK procedure after DALK demonstrate the safety and effectiveness of the procedure for patients.
这项前瞻性研究来自波兰的一个单一中心,旨在评估 60 例(96 眼)先前接受过深层板层角膜移植术(DALK)的患者与 60 例(108 眼)单纯接受 Femto-LASIK 视力矫正的患者相比,使用飞秒激光辅助原位角膜磨镶术(Femto-LASIK)矫正角膜移植术后残余屈光不正或屈光误差的效果。
研究组包括 60 例(96 眼)患者,他们在接受 DALK 后,使用 Femto-LASIK 程序矫正残余屈光不正。对照组由 60 例(108 眼)患者组成,他们在未接受 DALK 治疗的情况下接受 Femto-LASIK 视力矫正。两组患者在术前和术后 3、6、12 和 24 个月分别测量未矫正视力、最佳矫正视力和眼压。术前和术后 6、12 和 24 个月使用非接触式共焦显微镜评估角膜内皮细胞密度。
在研究组中,在 24 个月的观察期内,未观察到移植排斥、移植失代偿或角膜扩张。统计分析显示,研究组患者在术前和术后最佳矫正视力值之间没有显著差异(P>0.05)。相反,术后未矫正视力值明显高于术前(P>0.05)。
DALK 后 Femto-LASIK 视力矫正的效果表明该手术对患者安全有效。